Jan 25 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2021 Dec 31, 2020 Mar 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 3.47 3.17 4.80
(+9.2 pct) (-9.6 pct) (+12.7 pct)
Operating 662 mln 519 mln 800 mln
(+27.5 pct) (-7.2 pct) (+26.5 pct)
Recurring 671 mln 529 mln 800 mln
(+26.8 pct) (-5.7 pct) (+22.4 pct)
Net 457 mln 341 mln 540 mln
(+34.1 pct) (-11.3 pct) (+29.4 pct)
EPS 112.65 yen 81.97 yen 131.91 yen
Ann Div 15.00 yen 15.00 yen
-Q2 div NIL NIL
-Q4 div 15.00 yen 15.00 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T